Opiate use study in hospitalized seniors with nonsurgical conditions shows negative outcomes

May 17, 2017

In one of the first studies of its kind, nearly one-third of 10,000 older adults were prescribed opiate pain medications such as morphine, Percocet and OxyContin while hospitalized for non-surgical conditions, a course of care significantly linked to poor outcomes such as being restrained and requiring bladder catheterization, according to startling new research by Northwell Health physicians.

The study, "Opiate Prescribing in Hospitalized Older Adults: Patterns and Outcomes," is one of a pair focusing on in older adults scheduled for presentation at the American Geriatrics Society Meeting being held in San Antonio, TX from May 18-20. With legislation in recent years governing prescription drug monitoring and the use of medical marijuana in New York State, Northwell investigators Sutapa Maiti, MD, Liron Sinvani, MD, and Gisele Wolf-Klein, MD, joined colleagues to spotlight perspectives and practices influencing these timely and contentious topics.

The investigators agree that alternative pain management options should be integrated into the inpatient setting, including acupuncture, tai chi, heat therapy, and exercise tailored to patients' needs, among others.

"With , both physicians as well as patients understand they'll probably be living with chronic conditions such as congestive heart failure, arthritis or COPD for the rest of their lives, but what they really don't want is the pain associated with these conditions," said Dr. Wolf-Klein, director of geriatric education for Northwell Health. "This is all about quality of life. Patients' lives may be challenged by illness, but pain is something that we as physicians have a huge responsibility to manage properly."

Dr. Wolf-Klein is senior investigator of the second study, "Older Adults' Perspectives on Medical Marijuana Use," which found that 36 percent of seniors would be unlikely or extremely unlikely to use medical marijuana if prescribed. This reluctance exists despite 25 percent of the 93 study respondents reporting and 43 percent using prescription painkillers in the prior month.

Legislation enacted in recent years pertaining to pain management lent particular context to the research led by Dr. Wolf-Klein and Dr. Maiti, the first author of the opiate study and chief palliative fellow at Northwell Health. As of December 2015, 49 states initiated mandated legislation by the federal Centers for Medicare and Medicaid Services (CMS) on Prescription Drug Monitoring Programs, statewide electronic databases that collect prescription-dispensing data of controlled substances.

Meanwhile, since January 2016, medical practitioners in New York State have been officially able to prescribe medical marijuana for 10 qualifying conditions, including cancer, multiple sclerosis, chronic pain, neuropathies and inflammatory bowel disease, among others. Practitioners must complete a mandatory certification course to legally prescribe marijuana to their NY patients.

In the opiate study, Dr. Maiti and her team evaluated data on 10,529 patients aged 65 and older who were hospitalized over a one-year period in a large New York facility, comparing those who received opiates to those who did not. While hospitalized, 29.3 percent received opiates. And 83.9 percent of those patients were newly initiated or "naïve" to their use. Only 12.5 percent reported opiate use prior to hospitalization, while 11.2 percent were prescribed opiates at the time of discharge.

But seniors who received opiates while hospitalized were far more likely to suffer negative outcomes than peers who did not. These include being more than twice as likely to be restrained; taking no nutrition by mouth; having bladder catheters; and ordered to bed rest, among other associations. Patients on opiates also had a 50 percent longer average hospital stay and were more often readmitted within 30 days.

"What makes our study particularly interesting is that pain requiring opioids is expected in surgical or trauma patients, such as those with a hip fracture or after an accident," Dr. Maiti said. "However, we are uncovering the prevalence of opiate use in chronic illnesses, which is a factor we hear about in the news daily as Americans are battling an opioid epidemic. This is one of the first studies to demonstrate that opiate prescribing during hospitalization is associated with poor short-term outcomes."

"The use of opiates, when warranted, is a necessary component for providing high-quality care in the hospital setting," she added. "The real question is, should we be so quick to resort to opiates in patients who are elderly and naïve to opiates? Or should there be other ways to explore and tackle proper pain management?"

In the medical marijuana study, Dr. Wolf-Klein and her team capitalized on its new legality to determine what attitudes influenced its acceptance among seniors. Seventy-one percent of respondents, with an average age of 71, had chronic conditions, while 19 percent reported previous use of recreational marijuana. Only 3 percent had received a prescription for medical marijuana.

Thirty-six percent of participants said they would be unlikely or extremely unlikely to try medical marijuana if prescribed. Their concerns over its use included side effects (30 percent), addiction (19 percent), legal (9 percent), and lack of acceptance from loved ones (8 percent) and medical providers (3 percent).

No significant association was found between respondents' willingness to try medical marijuana and their age, gender, education level, chronic pain or other factors.

"It was interesting to see that people were not necessarily frightened about taking marijuana, but that those who admitted to using it in the past for recreational purposes would be much more willing to try it for than people who had never been on ," Dr. Wolf-Klein explained.

"I think the story is one we're just beginning to write," she added. "In the life of any kind of drug, a 12-month history is in its infancy. I don't know that we have enough experience in the great variety of conditions it's prescribed to have a profile of which patients are best helped, but if it seems to be of value, we need to help overcome some concerns or biases patients, families or practitioners might have."

Explore further: Poll: Marijuana safer than opioids, but moms shouldn't use

Related Stories

Poll: Marijuana safer than opioids, but moms shouldn't use

April 17, 2017
Americans think it's safer to use marijuana than opioids to relieve pain, but they were less comfortable with children and pregnant women using pot to treat medical conditions, according to a new Yahoo/Marist poll released ...

Maine could be 1st state to OK medical pot to treat addicts

April 19, 2016
Maine could become the first state to add addiction to opioid prescriptions and illegal narcotics like heroin to its list of conditions that qualify for medical marijuana.

No uptick in marijuana use by adolescents after states pass medical marijuana laws

October 19, 2016
Adults over the age of 25 increased their use of marijuana after their home states made changes to medical marijuana laws, according to new research by scientists at Columbia University's Mailman School of Public Health. ...

Colorado medical students defend physicians' right to recommend marijuana

January 17, 2017
Colorado students viewed the legalization of marijuana favorably, medicinal or otherwise, and generally felt that the medical use of marijuana is acceptable in the treatment of conditions approved by the Colorado Medical ...

Point/counterpoint debate takes aim at the opioid epidemic

April 11, 2017
Two experts with opposing views squared off on the hotly debated topic of how best to control the exploding opioid epidemic in the U.S.- with increasing regulation of physician prescribing practices or by better educating ...

States with medical marijuana laws see drop in prescriptions

April 28, 2017
(HealthDay)—Medical marijuana laws are associated with a decline in the number of prescriptions filled for Medicaid enrollees, according to a study published in the April issue of Health Affairs.

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.